WEBULL
News
PPBT
0.6575
+1.36%
0.0088
Weekly Report: what happened at PPBT last week (1222-1226)?
Weekly Report · 12/29/2025 09:47
Weekly Report: what happened at PPBT last week (1215-1219)?
Weekly Report · 12/22/2025 09:47
Purple Biotech Shareholders Approve Key Proposals at December Meeting
TipRanks · 12/16/2025 21:28
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 12/16/2025 21:05
Purple Biotech Ltd. Held Extraordinary General Meeting of Shareholders
Reuters · 12/16/2025 21:01
Weekly Report: what happened at PPBT last week (1208-1212)?
Weekly Report · 12/15/2025 09:52
Purple Biotech Announces Positive Preclinical Data at ESMO IO Congress 2025
TipRanks · 12/11/2025 12:30
Purple Biotech’s antibody platform shows anti-tumor activity
TipRanks · 12/11/2025 12:26
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 12/11/2025 12:05
Purple Biotech Announces New Preclinical Data From CAPTN-3 Tri-Specific Antibody Platform Presented At ESMO IO Congress 2025
Benzinga · 12/11/2025 12:05
Purple Biotech Reports CAPTN-3 Antibodies Show Strong Anti-Tumor Activity in Preclinical Studies
Reuters · 12/11/2025 12:00
PURPLE BIOTECH REPORTS POSITIVE NEW PRECLINICAL DATA DEMONSTRATING MULTI-ARM ANTI-TUMOR ACTIVITY ACROSS TWO CAPTN-3 TRI-SPECIFIC ANTIBODIES AT ESMO IMMUNO-ONCOLOGY CONGRESS 2025
Reuters · 12/11/2025 12:00
Weekly Report: what happened at PPBT last week (1201-1205)?
Weekly Report · 12/08/2025 09:51
Purple Biotech To Present New Preclinical Data From CAPTN-3 Platform Of Conditionally Activated Tri-Specific Antibodies At ESMO-IO 2025 Annual Congress
Benzinga · 12/04/2025 12:10
Purple Biotech to Present New Preclinical Data on CAPTN-3 Tri-Specific Antibody Platform at ESMO-IO 2025
Reuters · 12/04/2025 12:00
Weekly Report: what happened at PPBT last week (1124-1128)?
Weekly Report · 12/01/2025 09:48
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 11/24/2025 21:05
Purple Biotech's TyrNovo Has Been Granted European Patent Number EP3750530 Titled "COMBINATIONS OF IRS/STAT3 DUAL MODULATORS AND ANTI-CANCER AGENTS FOR TREATING CANCER"
Benzinga · 11/24/2025 20:59
Weekly Report: what happened at PPBT last week (1117-1121)?
Weekly Report · 11/24/2025 09:52
Purple Biotech Unveils November 2025 Corporate Presentation Highlighting Oncology Advances
TipRanks · 11/19/2025 22:27
More
Webull provides a variety of real-time PPBT stock news. You can receive the latest news about Purple Biotech Ltd through multiple platforms. This information may help you make smarter investment decisions.
About PPBT
Purple Biotech Ltd, formerly Kitov Pharma Ltd, is an Israel-based clinical-stage company that develops drugs that overcome tumor-immune evasion and drug resistancetreat pain. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The Company is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.